Research from Scott Small's lab at Columbia University suggests a different approach to tackling the disease, and a new startup company is now trying to turn that approach into treatments.
The goal of the ADRC HS Scholars Program is to reach talented young people from backgrounds underrepresented in science and medicine, and to encourage and inspire them toward careers in these fields.
Dr. Olajide Williams, Professor of Neurology and Associate Dean of Community Research and Engagement, was honored as a "Rising Leader" for his significant contributions in advancing health equity.
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
In recognition of Stroke Awareness Month, VP&S neurologist Joshua Willey, MD, shares important information about transient ischemic attacks (TIAs), also known as mini strokes.
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
